Second, while the APP/PS1 transgenic model successfully recapitulates key features of amyloid pathology, including plaque formation and associated neuroinflammation, it lacks other critical characteristics of human AD, most notably tau pathology and neurofibrillary tangles. The gene discussed is MAPT; the disease is amyloidosis.